G

GeneBioTech Co Ltd
KOSDAQ:086060

Watchlist Manager
GeneBioTech Co Ltd
KOSDAQ:086060
Watchlist
Price: 4 255 KRW Market Closed
Market Cap: ₩36.6B

Net Margin

4%
Current
Improving
by 0.7%
vs 3-y average of 3.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4%
=
Net Income
₩3.7B
/
Revenue
₩92.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4%
=
Net Income
₩3.7B
/
Revenue
₩92.3B

Peer Comparison

Country Company Market Cap Net
Margin
KR
GeneBioTech Co Ltd
KOSDAQ:086060
36.6B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
62st
Based on 2 632 companies
62st percentile
4%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

GeneBioTech Co Ltd
Glance View

Market Cap
36.6B KRW
Industry
Biotechnology

Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. The company is headquartered in Gongju, Chungcheongnam-Do. The company went IPO on 2006-04-28. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The firm distributes its products within the domestic market and to overseas markets, including America.

GeneBioTech Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
4%
=
Net Income
₩3.7B
/
Revenue
₩92.3B
What is GeneBioTech Co Ltd's current Net Margin?

The current Net Margin for GeneBioTech Co Ltd is 4%, which is above its 3-year median of 3.3%.

How has Net Margin changed over time?

Over the last 3 years, GeneBioTech Co Ltd’s Net Margin has increased from 0.7% to 4%. During this period, it reached a low of 0.7% on Sep 30, 2022 and a high of 4.4% on Sep 30, 2023.

Back to Top